Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing

[1]  Z. Herceg,et al.  Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system , 2019, Nucleic acids research.

[2]  Yuquan Wei,et al.  Targeted demethylation of the SARI promotor impairs colon tumour growth. , 2019, Cancer letters.

[3]  Shenmin Zhang,et al.  Dynamic Methylation Changes of DNA and H3K4 by RG108 Improve Epigenetic Reprogramming of Somatic Cell Nuclear Transfer Embryos in Pigs , 2018, Cellular Physiology and Biochemistry.

[4]  Heena Dhiman,et al.  CRISPR-Based Targeted Epigenetic Editing Enables Gene Expression Modulation of the Silenced Beta-Galactoside Alpha-2,6-Sialyltransferase 1 in CHO Cells. , 2018, Biotechnology journal.

[5]  R. Young,et al.  Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene , 2018, Cell.

[6]  Y. Kamei,et al.  Epigenetic modulation of Fgf21 in the perinatal mouse liver ameliorates diet-induced obesity in adulthood , 2018, Nature Communications.

[7]  R. Schmid,et al.  Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection. , 2018, Journal of visualized experiments : JoVE.

[8]  O. Elemento,et al.  TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells , 2017, Nature Genetics.

[9]  J. Fruchart.  Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia , 2017, Cardiovascular Diabetology.

[10]  O. Yang,et al.  A novel rapid and reproducible flow cytometric method for optimization of transfection efficiency in cells , 2017, PloS one.

[11]  H. Nishina,et al.  YAP determines the cell fate of injured mouse hepatocytes in vivo , 2017, Nature Communications.

[12]  Yonatan Stelzer,et al.  Editing DNA Methylation in the Mammalian Genome , 2016, Cell.

[13]  Kenichiro Hata,et al.  Targeted DNA demethylation in vivo using dCas9–peptide repeat and scFv–TET1 catalytic domain fusions , 2016, Nature Biotechnology.

[14]  Wei Li,et al.  DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells , 2016, Nature Genetics.

[15]  E. Maratos-Flier,et al.  Understanding the Physiology of FGF21. , 2016, Annual review of physiology.

[16]  J. Baur,et al.  Accumulation of 3-hydroxytetradecenoic acid: Cause or corollary of glucolipotoxic impairment of pancreatic β-cell bioenergetics? , 2015, Molecular metabolism.

[17]  Christopher M. Vockley,et al.  Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers , 2015, Nature Biotechnology.

[18]  S. Kliewer,et al.  Glucocorticoids regulate the metabolic hormone FGF21 in a feed-forward loop. , 2015, Molecular endocrinology.

[19]  J. Doudna,et al.  The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.

[20]  Ronald D. Vale,et al.  A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging , 2014, Cell.

[21]  Gangning Liang,et al.  Gene body methylation can alter gene expression and is a therapeutic target in cancer. , 2014, Cancer cell.

[22]  Y. Kamei,et al.  Ligand-Activated PPARα-Dependent DNA Demethylation Regulates the Fatty Acid β-Oxidation Genes in the Postnatal Liver , 2014, Diabetes.

[23]  Qi-Lian Liang,et al.  Effect of stable transfection with PHD3 on growth and proliferation of HepG2 cells in vitro and in vivo. , 2014, International journal of clinical and experimental medicine.

[24]  S. Bornstein,et al.  FGF21 Maintains Glucose Homeostasis by Mediating the Cross Talk Between Liver and Brain During Prolonged Fasting , 2014, Diabetes.

[25]  Christopher M. Vockley,et al.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors , 2013, Nature Methods.

[26]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[27]  Y. Kamei,et al.  Role of DNA Methylation in the Regulation of Lipogenic Glycerol-3-Phosphate Acyltransferase 1 Gene Expression in the Mouse Neonatal Liver , 2012, Diabetes.

[28]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[29]  J. Doudna,et al.  RNA-guided genetic silencing systems in bacteria and archaea , 2012, Nature.

[30]  T. Kodama,et al.  Regulation of the human PDZK1 expression by peroxisome proliferator‐activated receptor alpha , 2008, FEBS letters.

[31]  Masaaki Oda,et al.  QUMA: quantification tool for methylation analysis , 2008, Nucleic Acids Res..

[32]  T. Lundåsen,et al.  PPARα is a key regulator of hepatic FGF21 , 2007 .

[33]  S. Kliewer,et al.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. , 2007, Cell metabolism.

[34]  J. Flier,et al.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. , 2007, Cell metabolism.

[35]  Susan C. Brown,et al.  Lack of myostatin results in excessive muscle growth but impaired force generation , 2007, Proceedings of the National Academy of Sciences.

[36]  Han N. Lim,et al.  A multistep epigenetic switch enables the stable inheritance of DNA methylation states , 2007, Nature Genetics.

[37]  J. Wolff,et al.  Mechanism of plasmid delivery by hydrodynamic tail vein injection. II. Morphological studies , 2006, The journal of gene medicine.

[38]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[39]  R. Schulte‐Hermann,et al.  Cellular gene dose and kinetics of gene expression in mouse livers transfected by high-volume tail-vein injection of naked DNA. , 2002, DNA and cell biology.

[40]  J. Christman,et al.  5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy , 2002, Oncogene.

[41]  A. Wolffe,et al.  DNA methylation in health and disease , 2000, Nature Reviews Genetics.

[42]  Dexi Liu,et al.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.

[43]  D. M. Carlson,et al.  Gene expression following direct injection of DNA into liver. , 1994, Human gene therapy.

[44]  T. Horii,et al.  Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions. , 2018, Methods in molecular biology.

[45]  L. Belur,et al.  Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection , 2007, Nature Protocols.

[46]  T. Lundåsen,et al.  PPARalpha is a key regulator of hepatic FGF21. , 2007, Biochemical and biophysical research communications.